{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:05:40Z","timestamp":1794701140531,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1F1A1076054"],"award-info":[{"award-number":["2020R1F1A1076054"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15024-9","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:42:27Z","timestamp":1760449347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SOX4 enhances tumor progression and cisplatin resistance in orthotopic mouse xenograft model of head and neck squamous cell carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Hye-Bin","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Kyoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Eun","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Yeon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Chul","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Mi","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"15024_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2018.07.008","volume":"55","author":"JYK Chan","year":"2019","unstructured":"Chan JYK, Zhen G, Agrawal N. The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma. Semin Cancer Biol. 2019;55:1\u20137.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"15024_CR2","first-page":"3282","volume":"48","author":"WJ Blot","year":"1988","unstructured":"Blot WJ, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48(11):3282\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"15024_CR3","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"15024_CR4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","volume":"91","author":"S Marur","year":"2016","unstructured":"Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386\u201396.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"15024_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mdh001","volume":"15","author":"L Licitra","year":"2004","unstructured":"Licitra L, Vermorken JB. Is there still a role for neoadjuvant chemotherapy in head and neck cancer? Ann Oncol. 2004;15(1):7\u201311.","journal-title":"Ann Oncol"},{"key":"15024_CR6","volume":"163","author":"H Hu","year":"2023","unstructured":"Hu H, Li B, Wang J, Tan Y, Xu M, Xu W, et al. New advances into cisplatin resistance in head and neck squamous carcinoma: mechanisms and therapeutic aspects. Biomed Pharmacother. 2023;163:114778.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"15024_CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.34172\/joddd.2021.036","volume":"15","author":"F Atashi","year":"2021","unstructured":"Atashi F, Vahed N, Emamverdizadeh P, Fattahi S, Paya L. Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: a systematic review. J Dent Res Dent Clin Dent Prospects. 2021;15(3):219\u201325.","journal-title":"J Dent Res Dent Clin Dent Prospects"},{"issue":"15","key":"15024_CR8","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869\u201383.","journal-title":"Oncogene"},{"key":"15024_CR9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","volume":"53","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53:615\u201327.","journal-title":"Annu Rev Med"},{"issue":"2","key":"15024_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1534-5807(02)00223-X","volume":"3","author":"GE Schepers","year":"2002","unstructured":"Schepers GE, Teasdale RD, Koopman P. Twenty pairs of Sox: extent, homology, and nomenclature of the mouse and human Sox transcription factor gene families. Dev Cell. 2002;3(2):167\u201370.","journal-title":"Dev Cell"},{"issue":"Pt 1","key":"15024_CR11","first-page":"57","volume":"21","author":"S Carlos","year":"2020","unstructured":"Carlos S, Moreno. SOX4: the unappreciated oncogene. Semin Cancer Biol. 2020;21(Pt 1):57\u201364.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"15024_CR12","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1158\/0008-5472.CAN-05-3055","volume":"66","author":"P Liu","year":"2006","unstructured":"Liu P, et al. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 2006;66(8):4011\u20139.","journal-title":"Cancer Res"},{"issue":"7","key":"15024_CR13","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1158\/0008-5472.CAN-05-3456","volume":"66","author":"M Aaboe","year":"2006","unstructured":"Aaboe M, et al. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res. 2006;66(7):3434\u201342.","journal-title":"Cancer Res"},{"issue":"5","key":"15024_CR14","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.4049\/jimmunol.172.5.3319","volume":"172","author":"R Friedman","year":"2004","unstructured":"Friedman R, et al. Molecular and immunological evaluation of the transcription factor SOX-4 as a lung tumor vaccine antigen. J Immunol. 2004;172(5):3319\u201327.","journal-title":"J Immunol"},{"issue":"7","key":"15024_CR15","doi-asserted-by":"crossref","first-page":"e1000129","DOI":"10.1371\/journal.pgen.1000129","volume":"4","author":"K Yu","year":"2008","unstructured":"Yu K, et al. A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers. PLoS Genet. 2008;4(7):e1000129.","journal-title":"PLoS Genet"},{"issue":"21","key":"15024_CR16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215235","volume":"15","author":"X Deng","year":"2023","unstructured":"Deng X, et al. Pan-cancer analysis and experimental validation of SOX4 a s potential diagnosis, prognosis, and immunotherapy biomarker. Cancers (Basel). 2023;15(21):5235.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"15024_CR17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ccr.2013.04.020","volume":"23","author":"N Tiwari","year":"2013","unstructured":"Tiwari N, et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23(6):768\u201383.","journal-title":"Cancer Cell"},{"issue":"1","key":"15024_CR18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2012-05-428938","volume":"121","author":"P Ramezani-Rad","year":"2013","unstructured":"Ramezani-Rad P, et al. SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia. Blood. 2013;121(1):148\u201355.","journal-title":"Blood"},{"issue":"6","key":"15024_CR19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pros.22783","volume":"74","author":"L Wang","year":"2014","unstructured":"Wang L, et al. ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells. Prostate. 2014;74(6):647\u201358.","journal-title":"Prostate"},{"issue":"9","key":"15024_CR20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neo.2019.07.005","volume":"21","author":"HTH Thi","year":"2019","unstructured":"Thi HTH, et al. Microrna-130a modulates a radiosensitivity of rectal cancer by targeting SOX4. Neoplasia. 2019;21(9):882\u201392.","journal-title":"Neoplasia"},{"issue":"2","key":"15024_CR21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.canlet.2012.04.014","volume":"323","author":"C Chetty","year":"2012","unstructured":"Chetty C, et al. Blockade of SOX4 mediated DNA repair by SPARC enhances radioresponse in Medulloblastoma. Cancer Lett. 2012;323(2):188\u201398.","journal-title":"Cancer Lett"},{"issue":"15\u201316","key":"15024_CR22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/elps.202300255","volume":"45","author":"C Ai","year":"2024","unstructured":"Ai C, et al. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma. Electrophoresis. 2024;45(15\u201316):1408\u201317.","journal-title":"Electrophoresis"},{"key":"15024_CR23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1186\/s12885-015-1875-8","volume":"15","author":"TM Yoon","year":"2015","unstructured":"Yoon TM, et al. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma. BMC Cancer. 2015;15:888.","journal-title":"BMC Cancer"},{"issue":"1","key":"15024_CR24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archotol.1997.01900010022003","volume":"123","author":"BW O\u2019Malley Jr","year":"1997","unstructured":"O\u2019Malley BW Jr, Cope KA, Johnson CS, Schwartz MR. A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg. 1997;123(1):20\u20134.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"15024_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2011.11.027","volume":"317","author":"AK Vahle","year":"2012","unstructured":"Vahle AK, Kerem A, Ozt\u00fcrk E, Bankfalvi A, Lang S, Brandau S. Optimization of an orthotopic murine model of head and neck squamous cell carcinoma in fully immunocompetent mice: role of toll-like-receptor 4 expressed on host cells. Cancer Lett. 2012;317(2):199\u2013206.","journal-title":"Cancer Lett"},{"issue":"1","key":"15024_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/ijms22010247","volume":"22","author":"M Brand","year":"2020","unstructured":"Brand M, Laban S, Theodoraki MN, Doescher J, Hoffmann TK, Schuler PJ, et al. Characterization and differentiation of the tumor microenvironment of orthotopic and subcutaneously grown head and neck squamous cell carcinoma in immunocompetent mice. Int J Mol Sci. 2020;22(1):247.","journal-title":"Int J Mol Sci"},{"key":"15024_CR27","volume":"10","author":"Q Li","year":"2020","unstructured":"Li Q, Dong H, Yang G, Song Y, Mou Y, Ni Y. Mouse tumor-bearing models as preclinical study platforms for oral squamous cell carcinoma. Front Oncol. 2020;10:212.","journal-title":"Front Oncol"},{"issue":"22","key":"15024_CR28","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1128\/MCB.02179-06","volume":"27","author":"D Sinner","year":"2007","unstructured":"Sinner D, et al. Sox17 and Sox4 differentially regulate beta-catenin\/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol. 2007;27(22):7802\u201315.","journal-title":"Mol Cell Biol"},{"issue":"Pt 1","key":"15024_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","volume":"67","author":"D Grimm","year":"2020","unstructured":"Grimm D, et al. The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol. 2020;67(Pt 1):122\u201353.","journal-title":"Semin Cancer Biol"},{"issue":"7175","key":"15024_CR30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, et al. Endogenous human MicroRNAs that suppress breast cancer metastasis. Nature. 2008;451(7175):147\u201352.","journal-title":"Nature"},{"issue":"18","key":"15024_CR31","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1093\/nar\/gky755","volume":"46","author":"SJ Vervoort","year":"2018","unstructured":"Vervoort SJ, et al. SOX4 can redirect TGF-beta-mediated SMAD3-transcriptional output in a context-dependent manner to promote tumorigenesis. Nucleic Acids Res. 2018;46(18):9578\u201390.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"15024_CR32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41523-021-00248-2","volume":"7","author":"GA Mehta","year":"2021","unstructured":"Mehta GA, et al. SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2. NPJ Breast Cancer. 2021;7(1):40.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"15024_CR33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13578-021-00539-y","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, et al. SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study. Cell Biosci. 2021;11(1):23.","journal-title":"Cell Biosci"},{"key":"15024_CR34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12935-020-01568-2","volume":"20","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. SOX4 promotes the growth and metastasis of breast cancer. Cancer Cell Int. 2020;20:468.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"15024_CR35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.6004\/jnccn.2014.0142","volume":"12","author":"DG Pfister","year":"2014","unstructured":"Pfister DG, et al. Head and neck cancers, version 2. 2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(10):1454\u201387.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"15024_CR36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon JP, et al. Meta-analysis of chemotherapy in head and neck cancer (Mach-Nc): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4\u201314.","journal-title":"Radiother Oncol"},{"key":"15024_CR37","volume":"13","author":"X Tang","year":"2022","unstructured":"Tang X, et al. FN1 promotes prognosis and radioresistance in head and neck squamous cell carcinoma: from radioresistant HNSCC cell line to integrated bioinformatics methods. Front Genet. 2022;13:1017762.","journal-title":"Front Genet"},{"key":"15024_CR38","doi-asserted-by":"crossref","unstructured":"Tan XY et al. WNT2-SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer oncogene. 2023;42:3062\u201374.","DOI":"10.1038\/s41388-023-02816-1"},{"issue":"11","key":"15024_CR39","doi-asserted-by":"crossref","first-page":"e1990","DOI":"10.1038\/cddis.2015.290","volume":"6","author":"R Sun","year":"2015","unstructured":"Sun R, et al. SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2. Cell Death Dis. 2015;6(11):e1990.","journal-title":"Cell Death Dis"},{"issue":"4","key":"15024_CR40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1039\/D2MO00220E","volume":"19","author":"P Yue","year":"2023","unstructured":"Yue P, Han B, Zhao Y. Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches. Mol Omics. 2023;19(4):297\u2013307.","journal-title":"Mol Omics"},{"issue":"4","key":"15024_CR41","first-page":"785","volume":"13","author":"SJ Vervoort","year":"2019","unstructured":"Vervoort SJ, van Boxtel R, Coffer PJ. The unappreciated oncogene SOX4: challenge or opportunity in cancer therapy? Mol Oncol. 2019;13(4):785\u201398.","journal-title":"Mol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15024-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15024-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15024-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T01:06:13Z","timestamp":1760490373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15024-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15024"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15024-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of the Institutional Review Board of Chonnam National University Hwasun Hospital (Hwasun, South Korea; approval no. CNUHH2015028).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1570"}}